3E09X28
Introduction Nose to Oxazolidinones with Anti-infective, External Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 3 Administration |
| Body System | E Physiological Systems and Anatomical Regions |
| Operation | 0 Introduction |
| Body Part | 9 Nose |
| Approach | X External |
| Device | 2 Anti-infective |
| Qualifier | 8 Oxazolidinones |
Operation Definition
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
Procedure Overview
Introduction covers putting a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance into or onto a body region, other than blood or blood products, which fall under Transfusion instead. This wide-ranging family includes things like injecting anesthesia, infusing chemotherapy, instilling contrast for imaging, delivering anti-infective medications, or providing nutritional formula through a feeding route.
Because it spans so many substance types and delivery sites, this is one of the most frequently used families in the Administration section. A patient might encounter it during an epidural injection, a course of intravenous antibiotics, contrast dye given before a CT scan, or tube feeding after surgery; each represents a substance being placed into the body to achieve a specific therapeutic or diagnostic goal rather than a physical alteration of tissue.
Anatomy & Axis Detail
Nose
Introduction into the nose covers substances instilled into the nasal cavity, such as topical decongestants, anesthetics, or packing agents soaked in medication, addressing the nasal mucosa's role in airflow, humidification, and as an access point for sinus and epistaxis management. The nasal passages are narrow and lined with highly vascular mucosa prone to bleeding, so introduced substances are often used to constrict vessels before a procedure or to control hemorrhage directly. Coders should note that this differs from irrigation or packing coded elsewhere and from introduction into the respiratory tract further down the airway, so documentation needs to make clear whether the substance stayed within the nasal cavity itself or was directed toward the sinuses or nasopharynx.
Approach: External
External in Administration describes a substance applied directly onto the skin or a mucous membrane surface, such as a topical ointment, transdermal patch, or eye drop. It differs from Via Natural or Artificial Opening by never entering an internal passage, and from Percutaneous by involving no needle or puncture into the tissue.
Substance: Anti-infective
Anti-infective refers to administration of a substance intended to treat or prevent infection by killing or inhibiting microorganisms, including antibacterial, antifungal, antiviral, and antiparasitic agents given systemically or locally. It is distinguished from Serum, Toxoid and Vaccine, which primes the immune system for future protection rather than directly acting on an existing pathogen, and from Anti-inflammatory, which targets inflammation rather than the organism itself.
Qualifier: Oxazolidinones
Marks the administered drug as belonging to the oxazolidinone class of synthetic antibiotics, exemplified by agents like linezolid, used chiefly against resistant gram-positive organisms. This qualifier sits within Administration's anti-infective substance values and is chosen over Other Anti-infective whenever the drug class is specifically an oxazolidinone rather than an unclassified antimicrobial.
Coding & Documentation
Correct code assignment depends on identifying three things from the documentation: the substance given, matched to the correct qualifier value; the specific body region or route receiving it; and the approach used, such as percutaneous injection or an existing catheter. Physician orders and medication administration records are the primary support. The most common errors involve selecting an imprecise substance qualifier, for example coding a general anti-infective when the documentation specifies a particular drug category with its own value, or misidentifying the body region when a substance is delivered systemically versus locally, such as an intra-articular injection versus an intravenous one.
Commonly Confused With
This family is easily confused with Transfusion, but any blood or blood product is excluded here and must be coded under Transfusion instead, regardless of how it is delivered. It is also confused with routine medication administration that some facilities do not code separately when it is considered standard nursing care rather than a notable procedural event; coders should apply their facility's guidelines to determine which introductions rise to the level of a codable procedure.